Literature DB >> 25755508

Budd-Chiari syndrome following laparoscopic cholecystectomy.

Pooja D Amarapurkar1, Sunil J Parekh1, Punamiya Sundeep2, Deepak N Amarapurkar3.   

Abstract

Patients with thrombophilic disorder while undergoing intra-abdominal surgery may develop splanchnic vein thrombosis which can have dire consequences. Here we report a case of a 38-year-old female who developed acute Budd-Chiari syndrome after a laparoscopic cholecystectomy. She had polycythemia vera which was not diagnosed before surgery. In this report we want to highlight presurgical evaluation of routine biochemical tests and ultrasonography suggestive of myeloproliferative disorders were missed which led to the Budd-Chiari syndrome. We recommend a meticulous look at the routine evaluation done prior to cholecystectomy is essential.

Entities:  

Keywords:  ABC, acute Budd–Chiari; BCS, Budd–Chiari syndrome; Budd–Chiari syndrome; CT, computed tomography; ET, essential thrombocythemia; GB, gall bladder; IVC, inferior vena cava; JAK 2 mutation; LAP, leukocyte alkaline phosphatase score; MPD, myeloproliferative disorders; PMF, primary myelofibrosis; PNH, paroxysmal nocturnal hemoglobinuria; PV, polycythemia vera; PVT, portal venous thrombosis; RUQ, right upper quadrant; SAAG, serum ascites albumin gradient; TIPS, transjugular intrahepatic porta caval shunt; USG, ultrasonography; WBC, white blood cell; cholecystectomy; myeloproliferative disorder; polycythemia vera

Year:  2013        PMID: 25755508      PMCID: PMC4216828          DOI: 10.1016/j.jceh.2013.07.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  13 in total

Review 1.  Budd-Chiari syndrome: a review by an expert panel.

Authors:  Harry L A Janssen; Juan-Carlos Garcia-Pagan; Elwyn Elias; Gilles Mentha; Antoine Hadengue; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

Review 2.  The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies.

Authors:  Dominique-Charles Valla
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

Review 3.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 4.  Management of hepatic vascular diseases.

Authors:  Aurélie Plessier; Pierre-Emmanuel Rautou; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

5.  JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?

Authors:  Harry L A Janssen; Frank W G Leebeek
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

Review 6.  JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.

Authors:  O Kilpivaara; R L Levine
Journal:  Leukemia       Date:  2008-08-28       Impact factor: 11.528

Review 7.  Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome.

Authors:  J Hoekstra; H L A Janssen
Journal:  Neth J Med       Date:  2008-09       Impact factor: 1.422

8.  Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders.

Authors:  Robert Kralovics; Andreas S Buser; Soon-Siong Teo; Jorn Coers; Andre Tichelli; Anthonie P C van der Maas; Radek C Skoda
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

Review 9.  The role of thrombophilia in splanchnic vein thrombosis.

Authors:  Massimo Primignani; Pier Mannuccio Mannucci
Journal:  Semin Liver Dis       Date:  2008-09-23       Impact factor: 6.115

10.  The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

Authors:  Jean-Jacques Kiladjian; Francisco Cervantes; Franck W G Leebeek; Christophe Marzac; Bruno Cassinat; Sylvie Chevret; Dominique Cazals-Hatem; Aurélie Plessier; Juan-Carlos Garcia-Pagan; Sarwa Darwish Murad; Sebastian Raffa; Harry L A Janssen; Claude Gardin; Sophie Cereja; Carole Tonetti; Stéphane Giraudier; Bertrand Condat; Nicole Casadevall; Pierre Fenaux; Dominique C Valla
Journal:  Blood       Date:  2008-02-04       Impact factor: 22.113

View more
  2 in total

1.  Surgical Complications in Myeloproliferative Neoplasm Patient with Essential Thrombocythemia: A Case Report.

Authors:  Ikhwan Rinaldi; Abdul Muthalib; Teguh Wijayadi; Barlian Sutedja; Nelly Susanto; Lingga Magdalena; Jeremy Rafael Tandaju; Indy Larasati Wardhana; Kevin Winston
Journal:  Int Med Case Rep J       Date:  2022-09-12

Review 2.  Abdominal surgery in patients with essential thrombocythemia: A case report and systematic review of literature.

Authors:  Yi Zhu; HongGang Jiang; ZhiHeng Chen; BoHao Lu; JiaMing Wu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.